Ninety One North America’s Boston Scientific BSX Stock Holding History

Ninety One North America’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.34M	Sell	54,860 -34,159	-38%	-$1.85M	0.11%	87
2026 Q1	$5.59M	Buy	89,019 +11,301	+15%	+$904K	0.25%	57
2025 Q4	$7.41M	Buy	+77,718	New	+$7.62M	0.3%	53
2023 Q3	–	Sell	-115,350	Closed	-$6.24M	–	74
2023 Q2	$6.24M	Sell	115,350 -4,599	-4%	-$240K	0.26%	47
2023 Q1	$6M	Sell	119,949 -4,601	-4%	-$217K	0.27%	39
2022 Q4	$5.76M	Buy	124,550 +882	+0.7%	+$38.2K	0.28%	41
2022 Q3	$4.79M	Buy	123,668 +14,160	+13%	+$568K	0.23%	43
2022 Q2	$4.08M	Buy	+109,508	New	+$4.46M	0.18%	53

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ninety One North America's BSX Position: Q2 2026 in Review

Ninety One North America reduced its Boston Scientific (BSX) stake by 38% in Q2 2026, selling an estimated $1.85M and leaving 54,860 shares worth $2.34M. The position accounts for 0.11% of the portfolio, ranked #87.

Ninety One North America first reported a position in BSX in Q2 2022 and has held it in 8 quarters since. The position peaked at $7.41M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Ninety One North America held 54,860 shares of Boston Scientific worth $2.34M as of Q2 2026.
Ninety One North America sold 34,159 Boston Scientific shares in Q2 2026, an estimated $1.85M.
Boston Scientific made up 0.11% of Ninety One North America's portfolio in Q2 2026, its #87 holding.
Ninety One North America first reported a position in Boston Scientific in Q2 2022 and has held it in 8 quarters since.
Ninety One North America's Boston Scientific position peaked at $7.41M in Q4 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ninety One North America's 13F filing for Q2 2026, filed 16 Jul 2026.